YNYunus Nazlı

Yunus Nazlı

*This is an algorithmically generated author record based on publicly available information.

Yunus Nazlı has a total of 182 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Kalp ve Damar Cerrahisi (Cilt 1-2)

    by Ayşen Yaprak Kapkın, Hakan Hançer, Günseli Çubukçuoğlu Deniz, Cüneyt Konuralp, Serpil Nalbant, Mehmet Çakıcı, Deniz Süha Küçükaksu, Tümer Ulus, Onur Benli, Hafize Yalınız, et al.

  • Kalp Yaralanmaları

    by Necmettin Çolak, Yunus Nazlı, Ömer Çakır

  • Open Access

    The impact of additional right ventricular branch grafting on electrocardiographic and echocardiographic parameters

    by Onur Yıldırım, Yunus Nazlı, Necmettin Çolak, Omer Zuhtu Yondem, Özcan Özdemır

    Aims: This study aimed to evaluate the impact of additional coronary artery bypass grafting (CABG) to right ventricular (RV) branches on echocardiographic and electrocardiographic parameters, with a focus on RV function and electrical stability. Methods: A retrospective review was conducted on patients who underwent CABG with significant right coronary artery (RCA) disease between January 2017 and December 2022. Patients were included and divided into two groups: Group 1 (n = 34) received grafts only to the distal RCA branches (posterior descending artery or posterolateral branch); Group 2 (n = 34) underwent grafting to both the distal RCA and the RV branch. Preoperative and discharge periods, echocardiographic and electrocardiographic parameters were compared between groups. Results: Both groups had comparable baseline characteristics, including echocardiographic and electrocardiographic parameters. At discharge, tricuspid annular plane systolic excursion (TAPSE) was lower in Group 1 compared to Group 2 (11.7 ± 2.7 mm vs. 15.1 ± 2.3 mm; p < 0.001). The ratio of diastolic dysfunction was higher in Group 1 compared to Group 2 (91.2% vs. 61.8%; p < 0.001). The mean QT dispersion (54.6 ± 15.4 ms vs. 63.7 ± 18.5 ms; p = 0.031) and mean P wave dispersion (22.5 ± 5.3 ms vs. 26.2 ± 8.8 ms; p = 0.048) levels were lower in Group 2 compared to Group 1. Conclusion: Additional bypass grafting of the RV branch in patients with significant RCA disease was associated with improved RV function and more favorable electrocardiographic parameters.

  • Open Access

    The prognostic role of the CHA₂DS₂-VASc score in patients with acute myocardial infarction receiving extracorporeal membrane oxygenation following out-of-hospital cardiac arrest

    by Onur Yıldırım, Necmettin Çolak, Yunus Nazlı, Ömer Zühtü Yöndem, Sercan Okutucu

    Aims: The CHA₂DS₂-VASc scoring system has been widely used for stroke risk stratification in patients with atrial fibrillation, yet evidence regarding its prognostic value in other critical settings remains limited. This study aimed to assess the utility of the CHA₂DS₂-VASc score in predicting mortality in patients with acute myocardial infarction (AMI) who received veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support following out-of-hospital cardiac arrest. Methods: This retrospective study included 41 patients with AMI requiring VA-ECMO after OHCA. Baseline demographics, clinical characteristics, and prognostic scores, including CHA₂DS₂-VASc, SAVE (Survival After Veno-Arterial ECMO), Glasgow Coma Scale (GCS), and acute physiology and chronic health evaluation (APACHE) II were recorded. Patients were categorized into three risk groups based on the CHA₂DS₂-VASc score: low (0 points), moderate (1 point), and high (≥2 points). According to the SAVE score, patients were classified into five risk groups: class I (≥5 points), class II (1–4 points), class III (−4 to 0 points), class IV (−9 to −5 points), and class V (≤−10 points). The primary outcome was in-hospital mortality. Results: The overall in-hospital mortality rate was 58.5%. Patients with high risk group had a significantly higher mortality risk (HR: 3.12, 95% CI: 1.28-7.63, p=0.008). The SAVE score had the highest diagnostic performance, with a sensitivity of 81.2% and specificity of 76.5% (AUC=0.80). CHA₂DS₂-VASc (AUC=0.74) and APACHE II (AUC=0.72) also demonstrated good predictive performance. While CHA₂DS₂-VASc maintained a balanced sensitivity (70.8%) and specificity (64.7%), APACHE II had higher sensitivity (75.7%) but lower specificity (58.8%). GCS demonstrated the lowest diagnostic performance (AUC=0.68). Conclusion: While the SAVE score, a risk model specifically designed for VA-ECMO, provides a strong prognostic evaluation, the CHA₂DS₂-VASc score could be a simple and easily applicable tool for early risk stratification in this high-risk population.